Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zeo ScientifiX's ebitda for the twelve months ending Apr 30, 2026 was -$4.05M. For fiscal 2025 it was -$5.31M. The highest annual figure on record is -$5.25M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | -$5.31M | – |
| FY2024 | Oct 31, 2024 | -$5.25M | – |
| FY2023 | Oct 31, 2023 | -$6.28M | – |
| FY2022 | Oct 31, 2022 | -$8.51M | – |
| FY2021 | Oct 31, 2021 | -$12.69M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$493.00K | – |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | -$859.00K | – |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | -$648.00K | – |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | -$2.05M | – |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | -$1.38M | – |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | -$1.24M | – |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | -$1.55M | – |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | -$1.14M | – |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | -$1.22M | – |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | -$1.29M | – |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | -$2.92M | – |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | -$2.73M | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$1.24M | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | -$1.63M | – |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | -$937.66K | – |
See a number that looks wrong?